The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
Abstract Clinical trial endpoints must be carefully and intentionally selected so that the results of the trial can be used to inform policy- and decision-making. The relative importance of potential endpoints often depends on the stakeholder, with patients having different preferences to policymake...
Main Authors: | Kristian Thorlund, Davey Smith, Christopher Linsell, Nicholas White, Christopher Butler, David Boulware, Judith Currier, Ofir Harari, Edouard Lhomme, Nathalie Strub-Wourgaft, Stacey Adam, Edward Mills |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-04-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-023-00281-1 |
Similar Items
-
The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
by: Thorlund, K, et al.
Published: (2023) -
Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
by: An Wang, et al.
Published: (2023-06-01) -
Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints
by: Naim Alkhouri, et al.
Published: (2019-12-01) -
Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
by: An Wang, et al.
Published: (2024-02-01) -
Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics
by: Natalie Dodd, et al.
Published: (2018-08-01)